Vestal Point Capital, LP Sutro Biopharma, Inc. Transaction History
Vestal Point Capital, LP
- $1.69 Trillion
- Q4 2024
A detailed history of Vestal Point Capital, LP transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Vestal Point Capital, LP holds 2,570,000 shares of STRO stock, worth $4.81 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
2,570,000Holding current value
$4.81 Million% of portfolio
0.28%Shares
1 transactions
Others Institutions Holding STRO
# of Institutions
128Shares Held
59.9MCall Options Held
203KPut Options Held
33.6K-
Suvretta Capital Management, LLC New York, NY7.46MShares$14 Million0.57% of portfolio
-
Black Rock Inc. New York, NY6.91MShares$12.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.21MShares$7.87 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.64MShares$6.81 Million0.42% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.46MShares$4.6 Million0.0% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $97.5M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...